As of 2023, no GLP-1 transdermal systems have completed Phase 3 clinical trials or received regulatory approval
GLP-1 also slows gastric emptying, contributing to a longer feeling of fullness after meals and slower digestion of food, which helps moderate blood sugar levels
Moglabs.bio is a chemical supplier and is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act
GLP-1 (Glucagon-Like Peptide-1) receptor agonists are FDA-approved medications originally developed for diabetes management, now widely used for safe and effective weight loss
This is why physician supervision and nutritional coaching are not optional additions to GLP-1 treatment they are what determine whether the results last
Let's break down the good, the bad, and the ugly of the GLP-1 craze